Table: Phoenixbio -Q1 group results
Aug 12 (Reuters)-
Phoenixbio Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2016 Jun 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 337 mln 1.42
(+16.9 pct)
Operating 50 mln 354 mln
(+86.5 pct)
Recurring 4 mln 347 mln
(+132.6 pct)
Net 3 mln 299 mln
(+138.9 pct)
EPS 1.13 yen 103.62 yen
EPS Diluted 1.10 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Phoenixbio Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T
((Tokyo Headline News Desk +813 6441 1812))